机译:TP53突变在与治疗有关的急性髓性白血病的发生和发展中的作用
Department of Medicine, Division of Oncology, Washington University, St Louis, Missouri 63110, USA;
Department of Medicine, Jane Anne Nohl Division of Hematology, University of Southern California, Los Angeles, California 90089, USA;
Department of Pediatrics, Division of Hematology/Oneology, Washington University, St Louis, Missouri 63110, USA;
The Genome Institute, Washington University, St Louis, Missouri 63110, USA;
Department of Medicine, Division of Oncology, Washington University, St Louis, Missouri 63110, USA;
Department of Medicine, Division of Oncology, Washington University, St Louis, Missouri 63110, USA, Siteman Cancer Center, Washington University, St Louis, Missouri 63110, USA;
Department of Medicine, Division of Oncology, Washington University, St Louis, Missouri 63110, USA;
AstraZeneca, Gaithersburg, Maryland 20878, USA;
The Genome Institute, Washington University, St Louis, Missouri 63110, USA;
The Genome Institute, Washington University, St Louis, Missouri 63110, USA;
Department of Medicine, Division of Oncology, Washington University, St Louis, Missouri 63110, USA;
Division of Biostatistics, Washington University, St Louis, Missouri 63110, USA;
Department of Pathology and Immunology, Washington University, St Louis, Missouri 63110, USA;
Department of Medicine, Division of Oncology, Washington University, St Louis, Missouri 63110, USA, Siteman Cancer Center, Washington University, St Louis, Missouri 63110, USA;
The Genome Institute, Washington University, St Louis, Missouri 63110, USA, Siteman Cancer Center, Washington University, St Louis, Missouri 63110, USA, Department of Genetics, Washington University, St Louis, Missouri 63110, USA;
Department of Medicine, Division of Oncology, Washington University, St Louis, Missouri 63110, USA, Siteman Cancer Center, Washington University, St Louis, Missouri 63110, USA;
Department of Medicine, Division of Oncology, Washington University, St Louis, Missouri 63110, USA, Siteman Cancer Center, Washington University, St Louis, Missouri 63110, USA;
Department of Medicine, Division of Oncology, Washington University, St Louis, Missouri 63110, USA, Siteman Cancer Center, Washington University, St Louis, Missouri 63110, USA;
Department of Medicine, Division of Oncology, Washington University, St Louis, Missouri 63110, USA, Siteman Cancer Center, Washington University, St Louis, Missouri 63110, USA;
Department of Medicine, Division of Oncology, Washington University, St Louis, Missouri 63110, USA, Siteman Cancer Center, Washington University, St Louis, Missouri 63110, USA;
Department of Pediatrics, Division of Hematology/Oneology, Washington University, St Louis, Missouri 63110, USA;
Department of Medicine, Division of Oncology, Washington University, St Louis, Missouri 63110, USA, Siteman Cancer Center, Washington University, St Louis, Missouri 63110, USA;
The Genome Institute, Washington University, St Louis, Missouri 63110, USA, Siteman Cancer Center, Washington University, St Louis, Missouri 63110, USA, Department of Genetics, Washington University, St Louis, Missouri 63110, USA;
机译:TP53突变在与治疗有关的急性髓性白血病的发生和发展中的作用
机译:对治疗相关性和继发性急性髓细胞性白血病中异柠檬酸脱氢酶基因突变的评估,确定了由于单亲二体性而克隆发展为IDH2 R172K纯合性的患者。
机译:对与治疗有关的和继发性急性髓细胞性白血病中异柠檬酸脱氢酶基因突变的评估,确定了由于单亲二体性而克隆发展为IDH2 R172K纯合性的患者
机译:WGAN潜在空间嵌入在儿童急性髓性白血病中的爆炸鉴定。
机译:Egr1的丢失在小鼠白血病的发生中起作用,并且可能在急性髓细胞性白血病和与治疗有关的急性髓细胞性白血病的发展中起作用。
机译:TP53突变在与治疗有关的AML发生和发展中的作用
机译:TP53突变在治疗相关急性髓性白血病的起源和演化中的作用